Patient-reported outcome (PRO)-based symptom assessment in patients with advanced lung cancer receiving first-line combination immunotherapy: a protocol for a multicenter, prospective, observational study

被引：0

作者：

Yuanle Deng

Han Hu

Rong Jia

Wei Dai

Dengfeng Wang

Purong Zhang

Peng Zhang

Kai Cheng

Jianning Tang

Yan Wen

Xiang Zhou

Qiuling Shi

Zhujuan Xiong

Jin Zhou

机构：

[1] Sichuan Cancer Hospital & Institute,Department of Clinical Nutrition, Sichuan Clinical Research Center for Cancer

[2] Sichuan Cancer Center,Department of Medical Oncology, Sichuan Clinical Research Center for Cancer

[3] Affiliated Cancer Hospital of University of Electronic Science and Technology of China,Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer

[4] Sichuan Cancer Hospital & Institute,Gynecologic Oncology Center, Sichuan Clinical Research Center for Cancer

[5] Sichuan Cancer Center,Department of Breast Surgery, Sichuan Clinical Research Center for Cancer

[6] Affiliated Cancer Hospital of University of Electronic Science and Technology of China,Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer

[7] Sichuan Cancer Hospital & Institute,Department of Pharmacy, Sichuan Clinical Research Center for Cancer

[8] Sichuan Cancer Center,Department of Gastrointestinal Surgery, Sichuan Clinical Research Center for Cancer

[9] Affiliated Cancer Hospital of University of Electronic Science and Technology of China,School of Public Health

[10] Sichuan Cancer Hospital & Institute,undefined

[11] Sichuan Cancer Center,undefined

[12] Affiliated Cancer Hospital of University of Electronic Science and Technology of China,undefined

[13] Sichuan Cancer Hospital & Institute,undefined

[14] Sichuan Cancer Center,undefined

[15] Affiliated Cancer Hospital of University of Electronic Science and Technology of China,undefined

[16] Sichuan Cancer Hospital & Institute,undefined

[17] Sichuan Cancer Center,undefined

[18] Affiliated Cancer Hospital of University of Electronic Science and Technology of China,undefined

[19] Sichuan Cancer Hospital & Institute,undefined

[20] Sichuan Cancer Center,undefined

[21] Affiliated Cancer Hospital of University of Electronic Science and Technology of China,undefined

[22] Sichuan Cancer Hospital & Institute,undefined

[23] Sichuan Cancer Center,undefined

[24] Affiliated Cancer Hospital of University of Electronic Science and Technology of China,undefined

[25] Chongqing Medical University,undefined

来源：

BMC Pulmonary Medicine | / 23卷

关键词：

Patient-reported outcome; Lung cancer; Immunotherapy; Immune-related adverse events;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancer
Naminatsu Takahara
Yousuke Nakai
Hiroyuki Isayama
Takashi Sasaki
Yuji Morine
Kazuo Watanabe
Makoto Ueno
Tatsuya Ioka
Masashi Kanai
Shunsuke Kondo
Naohiro Okano
Kazuhiko Koike
Investigational New Drugs, 2023, 41 : 76 - 85
[42] Chinese multicentre prospective registry of breast cancer patient-reported outcome-reconstruction and oncoplastic cohort (PRO-ROC): a study protocol
Li, Lun
Yang, Benlong
Li, Hongyuan
Yin, Jian
Jin, Feng
Han, Siyuan
Liao, Ning
Shi, Jingping
Ling, Rui
Li, Zan
Ouyang, Lizhi
Wang, Xiang
Fu, Peifen
Ouyang, Zhong
Ma, Binlin
Wu, Xinhong
Wang, Haibo
Liu, Jian
Shao, Zhimin
Wu, Jiong
BMJ OPEN, 2019, 9 (12):
[43] Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab
Milowsky, Matthew I.
O'Donnell, Peter H.
Hoimes, Christopher J.
Petrylak, Daniel P.
Flaig, Thomas W.
Moon, Helen H.
Friedlander, Terence W.
Mar, Nataliya
McKay, Rana R.
Srinivas, Sandy
Gravis, Gwenaelle
Ramamurthy, Chethan
Bupathi, Manojkumar
Bracarda, Sergio
Wright, Phoebe
Hepp, Zsolt
Carret, Anne-Sophie
Yu, Yao
Dillon, Ryan
Kataria, Ritesh
Beaumont, Jennifer L.
Purnajo, Intan
Rosenberg, Jonathan E.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (12) : 1403 - 1414
[44] Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study
Ramalingam, Suresh S.
Novello, Silvia
Guclu, Salih Zeki
Bentsion, Dmitry
Zvirbule, Zanete
Szilasi, Maria
Bernabe, Reyes
Syrigos, Konstantinos
Byers, Lauren Averett
Clingan, Philip
Bar, Jair
Vokes, Everett E.
Govindan, Ramaswamy
Dunbar, Martin
Ansell, Peter
He, Lei
Huang, Xin
Sehgal, Vasudha
Glasgow, Jaimee
Bach, Bruce A.
Mazieres, Julien
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (32) : 3633 - +
[45] The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial
Trojan, Andreas
Leuthold, Nicolas
Thomssen, Christoph
Rody, Achim
Winder, Thomas
Jakob, Andreas
Egger, Claudine
Held, Ulrike
Jackisch, Christian
JOURNAL OF MEDICAL INTERNET RESEARCH, 2021, 23 (08)
[46] Docetaxel and gemcitabine combination as first-line treatment in advanced or metastatic nonsmall-cell lung cancer: a multicenter phase II study
Costa, A
Almodovar, T
Seada, J
Barata, F
Teixeira, E
Queiroga, H
Pires, S
LUNG CANCER, 2004, 45 : S79 - S79
[47] Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax
Candoni, Anna
Lazzarotto, Davide
Papayannidis, Cristina
Piccini, Matteo
Nadali, Giampaolo
Dargenio, Michelina
Riva, Marta
Fracchiolla, Nicola
Mellillo, Lorella
Dragonetti, Giulia
Del Principe, Maria Ilaria
Cattaneo, Chiara
Stulle, Manuela
Pasciolla, Crescenza
De Marchi, Roberta
Delia, Mario
Tisi, Maria Chiara
Bonuomo, Valentina
Sciume, Mariarita
Spadea, Antonio
Sartor, Chiara
Griguolo, Davide
Buzzatti, Elisa
Basilico, Claudia Maria
Sarlo, Chiara
Piccioni, Anna Lina
Cerqui, Elisa
Lessi, Federica
Olivieri, Attilio
Fanin, Renato
Luppi, Mario
Pagano, Livio
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (04) : E80 - E83
[48] Thoracic Radiotherapy Improves the Outcomes of Extensive Stage Small-Cell Lung Cancer Patients Receiving First-Line Immunotherapy: A Multicenter Retrospective Analysis
Yao, Y.
Li, B.
Song, R.
Yang, L.
Zou, B.
Wang, L.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S57 - S57
[49] KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy
Ghimessy, Aron Kristof
Gellert, Aron
Schlegl, Erzsebet
Hegedus, Balazs
Raso, Erzsebet
Barbai, Tamas
Timar, Jozsef
Ostoros, Gyula
Megyesfalvi, Zsolt
Gieszer, Balazs
Moldvay, Judit
Renyi-Vamos, Ferenc
Lohinai, Zoltan
Hoda, Mir Alireza
Klikovits, Thomas
Klepetko, Walter
Laszlo, Viktoria
Dome, Balazs
CANCERS, 2019, 11 (10)
[50] VALIDATION OF THE LUPUS IMPACT TRACKER (LIT), A PATIENT-REPORTED OUTCOME (PRO) TOOL, IN A PROSPECTIVE MULTICENTER LONGITUDINAL STUDY OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS
Jolly, M.
Kosinski, M.
Garris, C. P.
Oglesby, A. K.
VALUE IN HEALTH, 2012, 15 (07) : A515 - A515

← 1 2 3 4 5 →